Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
STTK | US
-0.78
-13.81%
Healthcare
Biotechnology
30/06/2024
02/06/2026
4.87
5.60
5.66
4.79
Shattuck Labs Inc. a clinical-stage biotechnology company develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154 which is in Phase 1 clinical trial for the treatment of ovarian fallopian tube and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin Texas.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
81.5%1 month
78.4%3 months
76.4%6 months
74.7%-
-
0.60
0.03
0.03
-3.62
18.32
-
-86.32M
232.43M
232.43M
-
-1.43K
-
704.50
-68.48
37.02
17.17
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.60
Range1M
2.58
Range3M
4.44
Rel. volume
1.34
Price X volume
4.05M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Enanta Pharmaceuticals Inc | ENTA | Biotechnology | 12.03 | 254.90M | -5.05% | n/a | 151.88% |
| MacroGenics Inc | MGNX | Biotechnology | 4.05 | 254.02M | -2.17% | n/a | 58.90% |
| Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 6.58 | 253.96M | -8.48% | n/a | 13.09% |
| Verrica Pharmaceuticals Inc | VRCA | Biotechnology | 5.79 | 247.05M | -1.86% | n/a | -348.20% |
| Entrada Therapeutics Inc. Common Stock | TRDA | Biotechnology | 6.64 | 247.01M | -3.91% | 5.77 | 14.99% |
| DiaMedica Therapeutics Inc | DMAC | Biotechnology | 5.77 | 246.65M | -1.20% | n/a | 0.73% |
| Abeona Therapeutics Inc | ABEO | Biotechnology | 5.69 | 246.46M | 1.07% | n/a | 31.63% |
| CytomX Therapeutics Inc | CTMX | Biotechnology | 3.16 | 242.67M | -8.41% | 7.73 | -37.61% |
| AC Immune SA | ACIU | Biotechnology | 2.42 | 239.44M | -1.63% | n/a | 0.00% |
| LogicBio Therapeutics Inc | LOGC | Biotechnology | 9.04 | 237.52M | -0.11% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Urban One Inc | UONEK | Broadcasting - Radio | 4.7 | 249.14M | -10.36% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.74 | 186.78M | -0.42% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 11.36 | 182.41M | 2.53% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 40.57 | 116.51M | -0.44% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.01 | 97.90M | 0.84% | 9.09 | 39.79% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 7.09 | 67.49M | 2.75% | n/a | 19.98% |
| ILAG | ILAG | Building Products & Equipment | 3.6016 | 65.04M | -4.21% | n/a | 5.48% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 9.37 | 58.67M | -0.64% | 14.48 | 7.10% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 19.59 | 29.83M | 25.34% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.11 | 16.22M | -2.63% | 0.03 | 16.03% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.62 | 0.53 | Cheaper |
| Ent. to Revenue | 18.32 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.60 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 76.43 | 72.80 | Par |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.03 | 0.25 | Cheaper |
| Market Cap | 232.43M | 3.66B | Emerging |